학술논문

Comparison of docetaxel and docetaxel–irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial
Document Type
Article
Source
In Annals of Oncology February 2005 16(2):294-299
Subject
Language
ISSN
0923-7534